Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., Akcea Therapeutics, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Broadway Financial Corporation, Cancer Genetics, Inc., Proteostasis Therapeutics, Inc., Rosetta Stone Inc., and Yintech Investment Holdings Limited

NEW YORK, Sept. 10, 2020 /PRNewswire/ -- Aimmune Therapeutics, Inc. (NASDAQ: AIMT) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of AIMT to Sociétés des Produits Nestlé, S.A. for $34.50 per share. If you are a AIMT...

from PR Newswire: https://ift.tt/3iig8d6